I think Labwire would need gross profits (annually) in the ballpark of 100 million to fetch a $2 share price, and probably revenues close to 500 million. Feels like a LONG way off with the current numbers. That's about 1/4 of the total defined market for drug testing. But who knows? Maybe the canines will sell well, too...
Even if I don't see Labwire as large of an opportunity as some, I do think it's at least a safe bet for gradual growth at the current price.
BTW, nice string of summary posts in the Labwire header. Very informative.